Amelioration of cirrhotic portal hypertension by targeted cyclooxygenase-1 siRNA delivery to liver sinusoidal endothelium with polyethylenimine grafted hyaluronic acid-Reference-Cited by-同舟云学术

Amelioration of cirrhotic portal hypertension by targeted cyclooxygenase-1 siRNA delivery to liver sinusoidal endothelium with polyethylenimine grafted hyaluronic acid

Published:2017-10 Issue:7 Volume:13 Page:2329-2339
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Lin Liteng,Cai Mingyue,Deng Shaohui,Huang Wensou,Huang Jingjun,Huang Xinghua,Huang Mingsheng,Wang Yong,Shuai Xintao,Zhu Kangshun

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference39 articles.

1. Liver cirrhosis;Schuppan;Lancet,2008

2. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension;Bosch;J Hepatol,2010

3. Vascular endothelial dysfunction in cirrhosis;Iwakiri;J Hepatol,2007

4. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites;López-Parra;Br J Pharmacol,2002

5. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs;Wolfe;N Engl J Med,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiocrine signaling in sinusoidal homeostasis and liver diseases;Journal of Hepatology;2024-09

2. Pathophysiology and therapeutic options for cirrhotic portal hypertension;The Lancet Gastroenterology & Hepatology;2024-07

3. Role of liver sinusoidal endothelial cells in the diagnosis and treatment of liver diseases;Sinusoidal Cells in Liver Diseases;2024

4. Biomaterial‐based gene therapy;MedComm;2023-06

5. Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells;Pharmaceutical Research;2023-01